TRANSGLYCIT

Trademark usage description

chemical reagents for medical research use, for production of iggs for therapeutic treatment, diagnostics and for quality control of igg in medical pr Read More

Classification Information

Class [001]
Chemical reagents for medical research use, for production of IgGs for therapeutic treatment, diagnostics and for quality control of IgG in medical production.

Classification kind code

Class [005]
Pharmaceuticals and herbicides

Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details

Serial Number

2154640

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 231 on 10^th Aug 2023	Limitation
Submitted for opposition 22 on 23^rd Mar 2023	Search Recorded
Submitted for opposition 20 on 23^rd Mar 2023	Examiner's First Report
Submitted for opposition 223 on 23^rd Mar 2023	Total Provisional Refusal
Submitted for opposition 256 on 17^th Oct 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 16^th Dec 2021	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 15^th Dec 2021	Formalized
Submitted for opposition 1 on 15^th Dec 2021	Created
Submitted for opposition 228 on 10^th Nov 2021	International Registration
Submitted for opposition 30 on 10^th Nov 2021	Filed

TRANSGLYCIT

Classification Information

Class [001]Chemical reagents for medical research use, for production of IgGs for therapeutic treatment, diagnostics and for quality control of IgG in medical production.

Classification kind code

Class [005]Pharmaceuticals and herbicides

Comment text

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [001]
Chemical reagents for medical research use, for production of IgGs for therapeutic treatment, diagnostics and for quality control of IgG in medical production.

Class [005]
Pharmaceuticals and herbicides